
The Menopause Society’s 2025 meeting heads to Orlando with sessions on longevity, hormones, cognition, and care innovation at midlife and beyond.
Morgan Ebert is managing editor of Contemporary OB/GYN® and Contemporary Pediatrics®. She joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio, before joining the Contemporary brands. You can reach her at mebert@mjhlifesciences.com.
The Menopause Society’s 2025 meeting heads to Orlando with sessions on longevity, hormones, cognition, and care innovation at midlife and beyond.
Supplemental molecular breast imaging more than doubled invasive cancer detection rates in women with dense breasts.
New SMFM guidance outlines key recommendations for diagnosing, counseling, and managing heart failure in pregnancy and postpartum.
On October 2, 2025, the FDA approved a generic version of mifepristone to be used in a regimen with misoprostol for abortion.
Take a quick look at everything you may have missed during the third quarter of 2025, including the latest FDA approvals, top stories, and exclusive interviews.
Take a quick look at everything you may have missed in September, including the latest FDA updates, top stories, and exclusive interviews.
Check out the top conferences happening in the fourth quarter of 2025.
Mothers with multiple adverse childhood experiences faced double the risk of preterm birth, highlighting intergenerational health effects.
A study of 1.2 million children found no causal link between prenatal opioid use and autism or ADHD.
A national poll finds most women underestimate diet’s role in reducing menopause symptoms, despite evidence for plant-based diets with soy.
The 2025 amendment updates diagnostic, treatment, and prevention strategies for recurrent urinary tract infections in women.
Universal EHR-based decision support eliminated racial disparities in adolescent chlamydia and gonorrhea testing in pediatric EDs.
An international review found rising maternal age, increasing complications, and ongoing disparities in maternity care across 3 nations.
Take a quick look at everything you may have missed in August, including the latest FDA updates, top stories, and exclusive interviews.
Vaginal estrogen tablets were not associated with increased risk of recurrent ischemic stroke in postmenopausal women with prior stroke.
Biennial HPV testing and higher vaccination rates could help South Korea eliminate cervical cancer up to a decade earlier than with current policy.
Epigenetic aging raises colorectal cancer risk in postmenopausal women, but higher fruit and vegetable intake may help offset this risk.
OTC oral contraceptives boost access, with more women starting effective birth control, especially uninsured and rural populations.
Hypertensive disorders in pregnancy affect fetal growth differently by sex, with males prioritizing growth and females adapting via placental development.
Counties with persistently low cervical cancer screening rates have nearly double the rates of late-stage diagnoses and mortality, study finds.
AI model predicts delivery timing from ultrasound images with high accuracy, offering a potential tool for preterm birth risk assessment.
Study finds women 65+ experience sexual dysfunction at rates similar to midlife women but report less distress over sexual health concerns.
Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.
FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.
Increasing daily sit-to-stand transitions lowered diastolic blood pressure in postmenopausal women, offering a simple strategy to support heart health.
A recent survey reveals significant gaps in public knowledge about pregnancy health, including misconceptions on weight gain, supplements, and vaccine safety.
Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.
Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.
SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.
A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.
Published: June 13th 2024 | Updated:
Published: September 10th 2024 | Updated:
Published: September 19th 2025 | Updated:
Published: December 10th 2024 | Updated:
Published: September 11th 2024 | Updated:
Published: February 1st 2025 | Updated: